Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Glenmark Pharmaceuticals Limited
Press Release Mar 12 2025
Business
Mar 12 2025
4 min read

Press Release Mar 12 2025

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 12, 2025, titled "Glenmark Pharma Expands Cardiometabolic Portfolio with the Launch of Empagliflozin and its Fixed-Drug Combinations in India".

View Attachment